1 IN. DI LETTURA
Dec 4 (Reuters) - Drugmaker Mylan Inc MYL.N said India-based Matrix Laboratories Ltd MAXL.BO, which is majority controlled by Mylan, received tentative U.S. regulatory approval to market the generic version of Gilead Sciences Inc's (GILD.O) AIDS drug Viread.
The U.S. Food and Drug Administration tentatively approved tenofovir disoproxil fumarate tablets (300 mg) under the President's Emergency Plan for AIDS Relief, the company said in a statement. (Reporting by Neha Pathania in Bangalore; Editing by Pratish Narayanan)